Targeting the host cysteinome leads to the discovery of broad-spectrum antivirals. The covalent inhibitor QL-XII-47 potently inhibits dengue virus. QL-XII-47 and related compounds block viral protein expression. QL-XII-47 exhibits broad-spectrum antiviral activity.